Long-term treatment with theophylline reduces neutrophils, interleukin-8 and tumor necrosis factor-α in the sputum of patients with chronic obstructive pulmonary disease

Pulmonary Pharmacology and Therapeutics

Volumn 20, Issue 1, 2007, Pages 46-51

  Iiboshi, Hirotoshi ^a   Ashitani, Jun ichi ^a   Katoh, Shigeki ^b   Sano, Arisa ^a   Matsumoto, Nobuhiro ^a   Mukae, Hiroshi ^c   Nakazato, Masamitsu ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

^c NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

COPD; IL 8; LPS; Neutrophils; Theophylline; THP 1; TNF

Indexed keywords

INTERLEUKIN 8; LIPOPOLYSACCHARIDE; THEOPHYLLINE; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTICLE; BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE RELEASE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; LONG TERM CARE; NEUTROPHIL COUNT; PRIORITY JOURNAL; SPIROMETRY; SPUTUM ANALYSIS; SYMPTOMATOLOGY;

ADMINISTRATION, ORAL; AGED; BRONCHODILATOR AGENTS; CELL LINE; DRUG ADMINISTRATION SCHEDULE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; MALE; NEUTROPHILS; PHOSPHODIESTERASE INHIBITORS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SPIROMETRY; SPUTUM; THEOPHYLLINE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33750436274     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2005.11.008     Document Type: Article

References (26)

1. Pauwels R.A., Buist A.S., Ma P., et al. GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. Respir Care 46 (2001) 798-825
2. Barnes P.J., Ito K., and Adcock I.M. Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone acetylase. Lancet 363 (2004) 731-733
3. Cosio B.G., Tsaprouni L., Ito K., et al. Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages. J Exp Med 200 (2004) 689-695
4. Adcock I.M. Glucocorticoid-regulated transcription factors. Pulm Pharmacol Ther 14 (2001) 211-219
5. Barnes P.J., Adcock I.M., and Ito K. Histone acetylation and deacetylation: importance in inflammatory lung diseases. Eur Respir J 25 (2005) 552-563
6. Barnes P.J. Theophylline: new perspectives for an old drug. Am J Respir Crit Care Med 167 (2003) 813-818
7. Yao P.L., Tsai M.F., Lin Y.C., et al. Global expression profiling of theophylline response genes in macrophages: evidence of airway anti-inflammatory regulation. Respir Res 6 (2005) 89
8. Nie H.X., Yang J., Hu S.P., et al. Effects of theophylline on CD4+ T lymphocyte, interleukin-5, and interferon γ in induced sputum of asthmatic subjects. Acta Pharmacol Sin 23 (2002) 267-272
9. Kobayashi M., Nasuhara Y., Betsuyaku T., et al. Effect of low-dose theophylline on airway inflammation in COPD. Respirology 9 (2004) 249-254
10. Broseghini C., Testi R., Polese G., et al. A comparison between inhaled salmeterol and theophylline in the short-term treatment of stable chronic obstructive pulmonary disease. Pulm Pharmacol Ther 18 (2005) 103-108
11. Culpitt S.V., de Matos C., Russell R.E., et al. Effect of theophylline on induced sputum inflammatory indices and neutrophil chemotaxis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 165 (2002) 1371-1376
12. Beeh K.M., Kornmann O., Buhl R., et al. Neutrophil chemotactic activity of sputum from patients with COPD: role of interleukin 8 and leukotriene B4. Chest 123 (2003) 1240-1247
13. Keatings V.M., Collins P.D., Scott D.M., et al. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 153 (1996) 530-534
14. Keatings V.M., Jatakanon A., Worsdell Y.M., et al. Effects of inhaled and oral glucocorticoids on inflammatory induces in asthma and COPD. Am J Respir Crit Care Med 155 (1997) 542-548
15. Ohta K., Fukuchi Y., Grouse L., et al. A prospective clinical study of theophylline safety in 3810 elderly with asthma or COPD. Respir Med 98 (2004) 1016-1024
16. Saetta M., Di Stefano A., Maestrelli P., et al. Airway eosinophilia in chronic bronchitis during exacerbations. Am J Respir Crit Care Med 150 (1994) 1646-1652
17. Perng D.W., Huang H.Y., Chen H.M., et al. Characteristics of airway inflammation and bronchodilator reversibility in COPD. Chest 126 (2004) 375-381
18. Hogg J.C., Chu F., Utokaparch S., et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 350 (2004) 2645-2653
19. De Boer W.I. Cytokines and therapy in COPD: a promising combination? Chest 121 (2002) 209S-218S
20. Di Stefano A., Capelli A., and Donner C.F. Role of interleukin-8 in the pathogenesis and treatment of COPD. Chest 126 (2004) 676-678
21. Pease J.E., and Sabroe I. The role of interleukin-8 and its receptors in inflammatory lung disease: implications for therapy. Am J Respir Med 1 (2002) 19-25
22. Hardaker E.L., Bacon A.M., Carlson K., et al. Regulation of TNF-alpha- and IFN-gamma-induced CXCL10 expression: participation of the airway smooth muscle in the pulmonary inflammatory response in chronic obstructive pulmonary disease. FASEB J 18 (2004) 191-193
23. Vernooy J.H., Kucukaycan M., Jacobs J.A., et al. Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum. Am J Respir Crit Care Med 166 (2002) 1218-1224
24. Rabe K.F., Magnussen H., and Dent G. Theophylline and selective PDE inhibitors as bronchodilators and smooth muscle relaxants. Eur Respir J 8 (1995) 637-642
25. Ram F.S., Jardin J.R., Atallah A., et al. Efficacy of theophylline in people with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respir Med 99 (2005) 135-144
26. Condino-Neto A., Vilela M.M., Cambiucci E.C., et al. Theophylline therapy inhibits neutrophil and mononuclear cell chemotaxis from chronic asthmatic children. Br J Clin Pharmacol 32 (1991) 557-561